Stay updated on JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial

Sign up to get notified when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.6.4 is now listed, replacing Revision: v3.6.3. This indicates a minor release of the page software rather than changes to study content or functionality.
    Difference
    0.1%
    Check dated 2026-07-28T13:46:43.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page revision updated from v3.6.2 to v3.6.3, signaling a new build of the page. This update does not alter the study details or data presented.
    Difference
    0.1%
    Check dated 2026-07-07T03:20:16.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.0 to v3.6.2, indicating a minor maintenance update to the page's underlying system. No substantive changes to study information or visible content are indicated by this patch.
    Difference
    0.1%
    Check dated 2026-06-29T18:07:22.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Recruitment status now shows the study is not enrolling participants. The page also received minor navigation and formatting adjustments, including new help sections and a standardization of the Intervention/Treatment label and revision history.
    Difference
    0.4%
    Check dated 2026-06-15T09:00:01.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4; this indicates a new page build/version and does not alter the study details or eligibility information.
    Difference
    0.1%
    Check dated 2026-06-08T04:39:50.000Z thumbnail image
  9. Check
    80 days ago
    Change Detected
    Summary
    The revision label changes from v3.5.3 to v3.5.4, indicating a platform/template update. This metadata update does not appear to alter the displayed study details or content.
    Difference
    0.1%
    Check dated 2026-05-18T03:30:28.000Z thumbnail image

Stay in the know with updates to JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.